Clinical Trials on Immune Thrombocytopenia in Austria

Total 3124 results

Medical University of Graz
Graz University of Technology

Not yet recruiting

Methimazole in Graves' Disease - Comparing the Computer-aided Treatment DigiThy Versus Usual Care

Graves Disease

Austria
Medical University of Vienna

Completed

Effect of High-Dose Prednisolone (Solu Dacortin®) Treatment on Choroidal and Optic Nerve Head Blood Flow in Humans

Regional Blood Flow | Optic Disk

Austria
Medical University of Vienna

Unknown

Bortezomib, Rituximab and Dexamethasone (BORID) for Relapsed/Refractory Mantle Cell Lymphoma

Lymphoma, Mantle-Cell

Austria
Medical University of Graz

Recruiting

Fecal Microbiota Transplantation in aGvHD After ASCT

Graft Versus Host Disease in GI Tract

Austria
Fresenius Medical Care Deutschland GmbH

Completed

Extracorporeal SPecific IgE Removal From the Plasma of Allergic Asthma Patients (ESPIRA-study) (ESPIRA)

Allergic Asthma

Austria
Novo Nordisk A/S

Completed

A Study to Look at How Safe Insulin NNC0471-0119 is and How it Works in People With Type 1 Diabetes Mellitus

Diabetes Mellitus, Type 1

Austria
Medical University of Vienna

Completed

Long-term Treatment Effect of Intravitreal Ant-VEGF in Branch Retinal Vein Occlusion

Branch Retinal Vein Occlusion

Austria
Arecor Limited

Completed

AT278 and NovoRapid® in Glucose Clamp Study

Diabetes Mellitus, Type 1

Austria
Eli Lilly and Company

Completed

A Study of LY2605541 (Insulin Peglispro) and Human Insulin Concentrations in Fat Tissue

Diabetes Mellitus, Type 1

Austria
Medical University of Graz

Completed

Effects of Infliximab on Insulin Sensitivity and Beta Cell Function in Insulin Resistant Human Obesity

Obesity | Metabolic Syndrome | Insulin Resistance

Austria
Novo Nordisk A/S

Completed

A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0143-0406 A 0.6 mmol/L in Subjects With Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

Austria
Novo Nordisk A/S

Completed

A Trial Investigating the Pharmacodynamic and Pharmacokinetic Properties of Insulin Degludec/Insulin Aspart 15 in Subjects With Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

Austria
Medical University of Vienna
National Bank of Austria

Unknown

Interventions to Prevent Adolescents With Type 1 Diabetes From Long-term Complications

Diabetes Mellitus, Type 1

Austria
Novo Nordisk A/S

Completed

A Study to Look at How Insulin NNC0471-0119 Works in the Body in People With Type 1 Diabetes When Injected by Insulin Pump

Diabetes Mellitus, Type 1

Austria
Novo Nordisk A/S

Completed

Comparison of Two NN1250 Formulations in Subjects With Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

Austria
Novo Nordisk A/S

Completed

Comparison of Hypoglycaemic Response Between NN1250 and Insulin Glargine in Type 1 Diabetics

Diabetes | Diabetes Mellitus, Type 1

Austria
Salzburger Landeskliniken

Enrolling by invitation

Propionic Acid in Multiple Sclerosis (MADAI)

Multiple Sclerosis

Austria
Medical University of Vienna

Withdrawn

Diagnostic and Prognostic Accuracy of FDHT-PET and Liquid Biopsies in Prostate Cancer

Prostate Cancer

Austria
Novo Nordisk A/S

Completed

A Multiple Dose Study Investigating Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0363-0845 in Participants With Type 1 Diabetes Pharmacokinetics and Pharmacodynamics: How Insulin NNC0363-0845 is Transported Throughout the Body and How It Works

Diabetes Mellitus, Type 1

Austria
Medical University of Vienna

Completed

TELEMS: Feasibility of Remote Patient Visits in MS (TELEMSRCT)

Multiple Sclerosis

Austria
Novo Nordisk A/S

Completed

Investigating the Postprandial Glucose Metabolism After Treatment With Faster-acting Insulin Aspart in Subjects With Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

Austria
Novo Nordisk A/S

Completed

A Randomised Proof-of-Principle Trial Investigating Pharmacodynamics, Pharmacokinetics, and Safety of NNC0143-0406 in Subjects With Type 1 Diabetes Mellitus

Diabetes | Diabetes Mellitus, Type 1

Austria
Novo Nordisk A/S

Completed

A Trial Investigating the Exposure of NN5401 in Young Adults and Elderly Subjects With Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

Austria
Novo Nordisk A/S

Completed

A Trial Investigating the Effect of NN1250 in Young and Elderly Subjects With Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

Austria
Novo Nordisk A/S

Completed

A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of FIAsp in Subjects With Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

Austria
Novo Nordisk A/S

Completed

A Randomised Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Faster-acting Insulin Aspart in Subjects With Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

Austria
Novo Nordisk A/S

Completed

A Trial to Test for Bioequivalence Between NN1045 and NN5401 in Subjects With Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

Austria
Arecor Limited

Completed

AT247, NovoRapid® and Fiasp® in Glucose Clamp Study

Diabetes Mellitus, Type 1

Austria
German Diabetes Center

Completed

Phielix et al.: Hepatic Fat Content and Adipokines

Type 2 Diabetes Mellitus

Austria
Medical University of Graz

Recruiting

Evaluation of Cryotherapy in Granuloma Pyogenicum

Cryotherapy Effect | Granuloma, Pyogenic

Austria
Prof. Dr. Matthias Preusser

Unknown

Study on Pembrolizumab for Recurrent Primary Central Nervous System Lymphoma (PCNSL)

Primary Central Nervous System Lymphoma

Austria
Medical University of Vienna
National Bank of Austria

Unknown

Bright Light Therapy as Possible Treatment Option for MS-Fatigue

Multiple Sclerosis | Fatigue

Austria
Novo Nordisk A/S

Completed

The Effect of Liraglutide Adjunct to Insulin on Glucagon Response to Hypoglycaemia in Subjects With Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

Austria
Medical University of Vienna

Completed

haMSter: a Novel Smartphone Communication Tool for People With MS

Multiple Sclerosis | M-health

Austria
Medical University of Graz
Menarini Group

Completed

Accuracy, Reliability and Safety of GlucoMen®Day, a New Generation Microdialysis Continuous Glucose Monitor

Type 1 Diabetes

Austria
Amgen

Active, not recruiting

Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer (RECITE)

Chemotherapy-induced Thrombocytopenia

United States, France, Austria, Hungary, Russian Federation, Romania, Spain, Turkey, Greece, Italy, Bulgaria, Canada, Portugal, Argentina, Poland, Mexico, Colombia, Peru, Brazil, Ukraine
Medical University of Graz

Completed

Incretin Effect on the Immunological Phenotype

Type 1 Diabetes

Austria
Medical University of Graz

Recruiting

Prostaglandin and Cannabinoid Receptors in EoE

Eosinophilic Esophagitis (EoE)

Austria
Medical University of Graz
Medical University of Vienna

Completed

Effects of Vitamin D Supplementation in Subjects With New Onset of Type 1 Diabetes

Type 1 Diabetes

Austria
Medical University of Graz
Menarini Group

Completed

Performance Study to Test the GlucoMen®Day System Using Intravascular and Subcutaneous Microdialysis in Subjects With Type 1 Diabetes

Type 1 Diabetes

Austria
Landsteiner Institut
University of Coimbra

Completed

Non Invasive Assessment of Liver Glycogen Kinetics and ATP Synthesis in Type1 Diabetics

Type 1 Diabetes Mellitus

Austria
Josef Smolen, Univ. Prof. Dr.

Unknown

A Study to Target the Type I IFN Receptor by Administrating Anifrolumab in RA Patients With a High IFN Signature (TarIFNiRA)

Rheumatoid Arthritis

Austria
Novartis Pharmaceuticals

Recruiting

Early Versus Late Ofatumumab (Kesimpta®) Use in Austrian RMS-Patients Over 2 Years (KRONOS)

Relapsing Multiple Sclerosis

Austria
Medical University of Vienna

Recruiting

Effect of Dupilumab on Aspirin Intolerance

AERD - Aspirin Exacerbated Respiratory Disease

Austria
Medical University of Vienna

Completed

Measurement of Total Retinal Blood Flow in Patients With Diabetes and Healthy Subjects

Type I Diabetes

Austria
Medical University of Graz

Recruiting

Diabetes Registry Graz for Biomarker Research (GIRO)

Type1diabetes | Type 2 Diabetes | Adiposity

Austria
Landeskrankenhaus Feldkirch

Completed

Nerve Conduction Velocity in Diabetic Children

Type 1 Diabetes Mellitus

Austria
Medical University of Vienna
Merck Sharp & Dohme LLC; European Foundation for the Study of Diabetes; Austrian... and other collaborators

Completed

Does Simvastatin Affect Insulin Sensitivity in Dyslipidemic Type 2 Diabetic Patients?

Cardiovascular Disease | Diabetes | Hypercholesterolemia

Austria
Medical University of Graz
Novo Nordisk A/S

Completed

Investigating the Effect of Liraglutide on the Endogenous Glucose Production During in Tye 1 Diabetes Subjects

Type 1 Diabetes Mellitus

Austria
Medical University of Vienna

Unknown

Methylphenidate as Treatment Option of Fatigue in Multiple Sclerosis (MS)

Multiple Sclerosis | Fatigue

Austria

3

Subscribe